How are companies adapting their processes to ensure the safety and efficacy of their products, while meeting the rising demand of refrigerated biologics? With biologics comprising over 40% of drugs in development, the need for precise temperature control is paramount. These drugs typically require refrigeration at temperatures between two to eight degrees Celsius (or even lower) and falling outside that range could affect efficacy and patient safety. This is an AI generated episode. Read the...